Bigul

Earum Pharmaceuticals Ltd - 542724 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Narendrakumar G Patel
28-04-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sushilaben N Patel
28-04-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Payal B Patel
27-04-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhumishth N Patel
27-04-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Narendrakumar G Patel
22-04-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sushilaben N Patel
22-04-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhumishth N Patel
22-04-2022
Bigul

Earum Pharmaceuticals Ltd - 542724 - Audited Financial Results For The Quarter And Year Ended On March 31,2022

Audited Financial Results for the quarter and year ended on March 31,2022
18-04-2022
Next Page
Close

Let's Open Free Demat Account